OrthoSon
PrivateLast Round
Series B
Sep 15, 2023
Total Funding Raised
$14.69M
Company Overview
OrthoSon operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series A round in May 2022.
OrthoSon is a medical technology company that develops minimally invasive, ultrasound-based treatments and bio-structural implants for degenerative disc disease and chronic back pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrthoSon Comparables
Compare OrthoSon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReGelTec, Inc. | 90% | |
| VIVEX Biologics | 80% | |
| DiscGenics | 78% |
For institutional investors. Book with your work email.
OrthoSon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 15, 2023 | ||||
| Series A | May 3, 2022 | ||||
| Seed | Nov 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OrthoSon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OTIF | Seed |
| Yonghua Capital | Series A |
| Oxford Technology and Innovations EIS Fund | Series A, Seed |
| Big Pi Ventures | Series A |
| Oxford Investment Consultants | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2022
Raised $11M from Yonghua Capital, Big Pi Ventures, and Oxford Technology.
For institutional investors. Book with your work email.
OrthoSon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OrthoSon's valuation, stock price, and market status.
Is OrthoSon a public or private company?
OrthoSon is a private company.
What is the current stock price of OrthoSon?
OrthoSon is a private company, so its shares have no public market price. Caplight tracks OrthoSon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OrthoSon worth (valuation)?
Valuation information for OrthoSon is not publicly available.
Can I buy OrthoSon stock?
OrthoSon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OrthoSon's last funding round?
OrthoSon's most recent funding round was Series B on September 15, 2023.
Who are the main investors in OrthoSon?
Key investors in OrthoSon include Oxford Technology and Innovations EIS Fund.
Will OrthoSon IPO soon?
No public IPO plans have been announced for OrthoSon.
How can I track OrthoSon secondary market activity?
Caplight tracks bids, offers, and trades in OrthoSon's shares on secondary markets.